Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Loading...
Community
/
France
/
Capital Goods
/
Exosens
EXENS
Exosens
Geopolitical Instability Will Pressure Global Defense Margins
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
02 Aug 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€33.50
16.6% overvalued
intrinsic discount
16 Aug
€39.05
1Y
101.1%
7D
0.1%
Loading
1Y
101.1%
7D
0.1%
Author's Valuation
€33.5
16.6% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€33.5
16.6% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-149m
576m
2020
2021
2022
2023
2024
2025
2026
2027
2028
Revenue €576.4m
Earnings €100.6m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
11.28%
Aerospace & Defense revenue growth rate
0.42%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.17%
Calculation
€100.61m
Earnings '28
x
25.41x
PE Ratio '28
=
€2.56b
Market Cap '28
€2.56b
Market Cap '28
/
62.19m
No. shares '28
=
€41.11
Share Price '28
€41.11
Share Price '28
Discounted to 2025 @ 7.17% p.a.
=
€33.40
Fair Value '25
